Science Explorer Back to mapMap
Discussion
Researcher · UCB Pharma (Belgium) · Belgium

François‐Xavier Mathy

François‐Xavier Mathy publishes mostly in Cellular and Molecular Neuroscience, Neurology and Pharmaceutical Science, on topics such as Advancements in Transdermal Drug Delivery, Dermatology and Skin Diseases and Drug Transport and Resistance Mechanisms.

OpenAlex
World rank
#2,214,823
of 7,710,434 ranked researchers
Rank in Belgium
#20,266
of 67,186
Works
19
Citations
986
Citations per work
51.9

What does François‐Xavier Mathy research?

François‐Xavier Mathy's work is mostly in Medicine (36%), Neuroscience (12%), Pharmacology, Toxicology and Pharmaceutics (10%).

Life Sciences21%Health Sciences36%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else842.7%
    1. Medicine736.0%
    1. Neuroscience211.5%
    2. Pharmacology, Toxicology and Pharmaceutics29.8%
  1. 1Cellular and Molecular Neuroscience12% of their works
  2. 2Neurology10% of their works
  3. 3Pharmaceutical Science10% of their works
  4. 4Pharmacology10% of their works
  5. 5Dermatology8% of their works
  6. 6Oncology8% of their works

Research topics

Which keywords describe François‐Xavier Mathy's research?

The keywords of their largest research topics: Oxidative Stress, Nuclear Receptors, Dopaminergic Neurons, Parkinson's Disease, ATP-dependent Transporters, Filaggrin, Microneedles and Multidrug Resistance.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Oxidative Stress82 topics
  2. Nuclear Receptors72 topics
  3. Dopaminergic Neurons62 topics
  4. Parkinson's Disease62 topics
  5. ATP-dependent Transporters51 topic
  6. Filaggrin51 topic
  7. Microneedles51 topic
  8. Multidrug Resistance51 topic
  9. Skin Microbiome51 topic
  10. Solid Lipid Nanoparticles51 topic
  11. Antibiotic Pharmacokinetics41 topic
  12. Antiepileptic Drugs41 topic
  13. Critically Ill Patients41 topic
  14. Genetic Risk Factors41 topic
  15. Prenatal Exposure41 topic
  16. a-Synuclein41 topic
  17. Neurotransmission31 topic
  18. Synaptic Plasticity31 topic
  19. NR4A221 topic
  20. Nurr121 topic

Where does François‐Xavier Mathy work?

François‐Xavier Mathy's main affiliation in the publication record is UCB Pharma (Belgium), Belgium.

How many publications and citations does François‐Xavier Mathy have?

OpenAlex counts 19 works and 986 citations for François‐Xavier Mathy, an h-index of 12, ranking #2,214,823 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about François‐Xavier Mathy. Posts are plain text and can be reported.